Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics (NASDAQ:BJDX) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

Is BJDX or CODX more profitable?

Bluejay Diagnostics has a net margin of 0.00% compared to Co-Diagnostics' net margin of -1,025.45%. Co-Diagnostics' return on equity of -60.16% beat Bluejay Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bluejay Diagnostics	N/A	-322.46%	-262.96%
Co-Diagnostics	-1,025.45%	-60.16%	-52.69%

Do analysts prefer BJDX or CODX?

Co-Diagnostics has a consensus target price of $5.50, suggesting a potential upside of 1,807.73%. Given Co-Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Co-Diagnostics is more favorable than Bluejay Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bluejay Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Co-Diagnostics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Do insiders and institutionals have more ownership in BJDX or CODX?

18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are held by institutional investors. 0.1% of Bluejay Diagnostics shares are held by insiders. Comparatively, 8.4% of Co-Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has higher valuation & earnings, BJDX or CODX?

Bluejay Diagnostics has higher earnings, but lower revenue than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bluejay Diagnostics	$250K	9.66	-$7.72M	-$379.74	0.00
Co-Diagnostics	$3.91M	2.48	-$37.64M	-$1.17	-0.25

Does the media favor BJDX or CODX?

In the previous week, Bluejay Diagnostics' average media sentiment score of 0.00 equaled Co-Diagnostics'average media sentiment score.

Company	Overall Sentiment
Bluejay Diagnostics	Neutral
Co-Diagnostics	Neutral

Which has more volatility & risk, BJDX or CODX?

Bluejay Diagnostics has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Summary

Co-Diagnostics beats Bluejay Diagnostics on 10 of the 15 factors compared between the two stocks.